Related Experiment Video

Updated: Jun 3, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation

Junxi Wu1, Jun Li, Nannan Zhang

  • 1Department of Internal Medicine, Medical Pharmacology and Physiology and Nutrition and Exercise Physiology, Dalton Cardiovascular Research Center, University of Missouri-Columbia, 65211, USA.

Basic Research in Cardiology
|March 23, 2011
PubMed

Insights

Stem cell therapy shows promise for ischemic heart disease, but direct cardiac regeneration is limited. Current research explores inflammation and stem cell fate for improved cardiac repair strategies.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Ischemic heart diseases are a leading global cause of death.
  • Adult hearts contain cardiac stem cells (CSCs), suggesting potential for myocardial repair.
  • Previous stem cell therapies (hematopoietic, mesenchymal) showed limited efficacy.

Purpose of the Study:

  • To review the role of stem cells in treating ischemic heart disease.
  • To explore the interaction between inflammation and stem cells in cardiac repair.
  • To examine stem cell fate and its impact on therapeutic outcomes.

Main Methods:

  • Literature review focusing on stem cell interactions and fate.
  • Analysis of mechanisms underlying stem cell-mediated cardiac improvement.
  • Synthesis of current research on stem cell therapies for heart disease.

Main Results:

  • Stem cell-mediated cardiac improvement involves complex mechanisms beyond direct regeneration.
  • Inflammation plays a crucial role in the interaction between stem cells and the cardiac environment.
  • The fate and behavior of stem cells in the microcirculation significantly influence therapeutic success.

Conclusions:

  • Direct cardiac regeneration by stem cells is not the primary mechanism for functional improvement.
  • Understanding stem cell-inflammation interactions and microcirculatory fate is key to advancing stem cell therapies for heart disease.
  • Future strategies should focus on optimizing these factors for enhanced cardiac repair.

More Related Videos

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...